Publication | Open Access
Subcutaneous tocilizumab in adults with severe and critical COVID-19: A prospective open-label uncontrolled multicenter trial
37
Citations
38
References
2020
Year
Long CovidCovid-19 PandemicSubcutaneous TocilizumabCovid-19 EpidemiologyPublic HealthMedicineEpidemiologyCritical Covid-19Covid-19
| Year | Citations | |
|---|---|---|
Page 1
Page 1